Neola Medical AB (OSTO:NEOLA) Beta: 1.4331 (As of Jun. 28, 2026)


OSTO:NEOLA Neola Medical AB OSTO:NEOLA
29 GF Score
Price kr0.92
! 1 Warning Sign
View Full Analysis

What is Neola Medical AB Beta?

Neola Medical AB OSTO:NEOLA +1.67% 29 Beta is 1.4331 as of Jun. 28, 2026. GuruFocus rates OSTO:NEOLA with a GF Score™ of 29/100. The stock has 1 warning sign investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-28), Neola Medical AB's Beta is 1.4331.


Neola Medical AB  (OSTO:NEOLA) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Neola Medical AB Beta Related Terms


Neola Medical AB Beta Historical Data

* Premium members only.

The historical data trend for Neola Medical AB's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neola Medical AB Beta Chart

Neola Medical AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial 0.00 0.00 1.46 2.03 1.58

Neola Medical AB Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.03 1.91 1.85 1.66 1.58

OSTO:NEOLA vs ABT, SYK, MDT: Beta Comparison

For the Medical Devices subindustry, Neola Medical AB's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neola Medical AB Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Neola Medical AB's Beta distribution charts can be found below:

* The bar in red indicates where Neola Medical AB's Beta falls into.


OSTO:NEOLA
29GF Score
Neola Medical AB OSTO:NEOLA
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neola Medical AB Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.4331 mean?
Neola Medical AB (OSTO:NEOLA) has a Beta of 1.4331 as of Jun. 28, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Neola Medical AB and its competitors.
Is Neola Medical AB's Beta too high?
Neola Medical AB's current Beta is 1.4331. Overall, Neola Medical AB has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Neola Medical AB's Beta compare to ABT and SYK?
Neola Medical AB's Beta of 1.4331 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Neola Medical AB and its competitors. Neola Medical AB's current Beta is 1.4331. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neola Medical AB stock overvalued right now?
Neola Medical AB (OSTO:NEOLA) has a current Beta of 1.4331. The current Beta is 1.4331. Neola Medical AB's overall GF Score™ is 29/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Neola Medical AB (OSTO:NEOLA), the current Beta is 1.4331 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Neola Medical AB Business Description

Address Scheelevagen 27, Ideon Science Park, Gateway 9th fl oor, Lund, SWE, 223 63
Neola Medical AB is revolutionizing neonatal intensive care with NEOLA, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a technology that measures lung volume changes and oxygen gas concentration. NEOLA has the potential to provide care, fewer days in intensive care, and healthier lives for preterm born infants. The company is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to health care.
29GF Score

Get the complete analysis for OSTO:NEOLA

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.92
Price